In accordance with the agreement, Mako will become a wholly owned subsidiary of Stryker.
Mako shareholders will receive $30 per share in cash when the merger officially goes through, according to the report.
More Articles on Supply Chain Transactions:
Valeant Pharmaceuticals Acquires Solta Medical
Myco Medical, Novation Enter Private-Label Contract
MediPurpose, EKF Diagnostics Sign Private Label Deal
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
